Snowball logo
logo
XENO

Xeno Transplants Corporation

XENO • OTCCE
$0.0001$0.00  (0%)
Estimate
Beta
-34.361
About the company
Ticker
XENO
ISIN
US98410N1072
Country
United States of America
Sector (GICS)
Healthcare
Xeno Transplants Corporation operates as a bio-technology research and development company. The company, through a license agreement with Massachusetts General Hospital, intends to develop, manufacture, distribute, and use products and processes for public use with regard to xenotransplantation. The Xenotransplantation is intended to address the problems arising from the limited supply of available human cells, tissues, and organs for transplantation by developing technologies to permit the transplantation of cells, tissues, and organs from other species into humans, such as swine. Xeno Transplants Corporation was incorporated in 2004 and is based in Brookline, Massachusetts.

Frequently asked questions

What sector does Xeno Transplants Corporation (XENO) operate in?

Xeno Transplants Corporation belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Xeno Transplants Corporation (XENO) current stock price?

As of the latest data, Xeno Transplants Corporation stock price is $0.00, with a previous close of $0.00.

Does Xeno Transplants Corporation (XENO) pay dividends?

No. Xeno Transplants Corporation does not pay a dividend.

What is Xeno Transplants Corporation (XENO) beta (volatility) score?

Xeno Transplants Corporation has a beta of -34.361, indicating lower volatility than the overall market.